| Copper | Approved Investigational | DSE | 29940 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of DSE mRNA | 6q22.1 | |
| Copper | Approved Investigational | DST | 667 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of DST mRNA | 6p12.1 | |
| Copper | Approved Investigational | DTL | 51514 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of DTL mRNA | 1q32.3 | |
| Copper | Approved Investigational | DTYMK | 1841 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of DTYMK mRNA | 2q37.3 | |
| Copper | Approved Investigational | DUSP1 | 1843 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of DUSP1 mRNA | 5q35.1 | |
| Copper | Approved Investigational | DUSP10 | 11221 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of DUSP10 mRNA | 1q41 | |
| Copper | Approved Investigational | DUSP2 | 1844 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of DUSP2 mRNA | 2q11.2 | |
| Copper | Approved Investigational | DUSP5 | 1847 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of DUSP5 mRNA | 10q25.2 | |
| Copper | Approved Investigational | DUSP5 | 1847 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of DUSP5 mRNA | 10q25.2 | |
| Copper | Approved Investigational | DUSP8 | 1850 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of DUSP8 mRNA | 11p15.5 | |
| Copper | Approved Investigational | DUSP9 | 1852 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of DUSP9 mRNA | Xq28 | |
| Copper | Approved Investigational | DUT | 1854 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of DUT mRNA | 15q21.1 | |
| Copper | Approved Investigational | DYNLL2 | 140735 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of DYNLL2 mRNA | 17q22 | |
| Copper | Approved Investigational | DYRK3 | 8444 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of DYRK3 mRNA | 1q32.1 | |
| Copper | Approved Investigational | E2F1 | 1869 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of E2F1 mRNA | 20q11.22 | |
| Copper | Approved Investigational | E2F7 | 144455 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of E2F7 mRNA | 12q21.2 | |
| Copper | Approved Investigational | E2F8 | 79733 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of E2F8 mRNA | 11p15.1 | |
| Copper | Approved Investigational | EAF1 | 85403 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of EAF1 mRNA | 3p25.1 | |
| Copper | Approved Investigational | EARS2 | 124454 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EARS2 mRNA | 16p12.2 | |
| Copper | Approved Investigational | EBP | 10682 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EBP mRNA | Xp11.23 | |
| Copper | Approved Investigational | ECM2 | 1842 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ECM2 mRNA | 9q22.31 | |
| Copper | Approved Investigational | EDIL3 | 10085 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of EDIL3 mRNA | 5q14.3 | |
| Copper | Approved Investigational | EED | 8726 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of EED mRNA | 11q14.2 | |
| Copper | Approved Investigational | EEF2K | 29904 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EEF2K mRNA | 16p12.2 | |
| Copper | Approved Investigational | EEF2KMT | 196483 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of EEF2KMT mRNA | 16p13.3 | |